Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...
Alphabet (NASDAQ:GOOGL) stock took a hit last week after its Q4 earnings report received a thumbs down from Wall Street. The market’s ...
Often dubbed the "Masters of the Universe," Goldman Sachs is the elite and clandestine top-tier investment bank that’s had a hand in some of the largest and most notable deals on Wall Street.
Goldman Sachs adjusted its outlook on Willis Towers Watson (NASDAQ:WTW), reducing the 12-month price target to $378 from the previous figure. Despite the adjustment, the firm maintained a Buy rating ...
Whales with a lot of money to spend have taken a noticeably bullish stance on Goldman Sachs Gr. Looking at options history for Goldman Sachs Gr (NYSE:GS) we detected 21 trades. If we consider the ...
Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...
Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Gr (NYSE:GS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Victory Capital (NASDAQ:VCTR – Free Report) had its target price increased by Barclays from $70.00 to $75.00 in a research ...
Fintel reports that on January 30, 2025, Goldman Sachs upgraded their outlook for RH (NYSE:RH) from Sell to Neutral. As of January 29, 2025, the average one-year price target for RH is $467.74/share.
Peloton Interactive, Inc. (NASDAQ:PTON – Get Free Report) shares were up 7.2% during mid-day trading on Monday after The ...
Fortinet, Inc. (NASDAQ:FTNT – Get Free Report)’s share price reached a new 52-week high on Tuesday after Susquehanna raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results